Clinical Trials Browser

Alzheimer Disease, Anxiety Disorders, Breast Neoplasms, Depression, Fatigue, Lung Neoplasms, Melanoma, Multiple Myeloma, Neoplasms, Prostatic Neoplasms

NCT06987708 2025-12-09

Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers

Phase NA Not yet recruiting

67 enrolled

Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance

NCT07253103 2025-11-28

Effects of a Resistance Physical Exercise Program in Multiple Myeloma Patients

Phase NA Not yet recruiting

50 enrolled

Plasma cell

Motor Activity, Multiple Myeloma, Neoplasms

NCT07069751 2025-09-15

HiFi-MM

Phase NA Not yet recruiting

62 enrolled

Plasma cell

Smoldering Multiple Myeloma

NCT07070960 2025-07-17

CAR-T

Phase NA Not yet recruiting

35 enrolled

Plasma cell

Multiple Myeloma

NCT06971848 2025-07-11

ETCABIO

Phase NA Not yet recruiting

70 enrolled

GastrointestinalLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellThoracic

Immunoglobulin Light-chain Amyloidosis, Esophageal Squamous Cell Carcinoma, Mesothelioma, Malignant, Carcinoma, Bronchogenic, Heart Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Follicular, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Cholangiocarcinoma, Neoplasms, Plasma Cell

NCT07034755 2025-07-02

Phase II Clinical Study on the Safety and Efficacy of Combined CAR-T Therapy Following Autologous Stem Cell Transplantation in Multiple Myeloma

Phase NA Not yet recruiting

20 enrolled

Plasma cell

Multiple Myeloma

NCT07040189 2025-06-27

GustaborPilot

Phase NA Not yet recruiting

51 enrolled

GastrointestinalPlasma cell

Gastrointestinal Neoplasms, Multiple Myeloma, Taste Disorders

NCT07018271 2025-06-12

A Study on the Use of Sulpegfilgrastim to Prevent the Incidence of Neutropenia With Infection in Newly Diagnosed Non-transplant Multiple Myeloma Patients

Phase NA Not yet recruiting

24 enrolled

Plasma cell

Multiple Myeloma, Neutropenia

NCT07015021 2025-06-11

DKPD

Phase NA Not yet recruiting

72 enrolled

Plasma cell

Multiple Myeloma

NCT06988020 2025-05-30

MM-ZTE-II

Phase NA Not yet recruiting

45 enrolled

Plasma cell

Multiple Myeloma

NCT06888752 2025-03-21

LCAR-M61SQ in Treatment of Relapsed/Refractory Multiple Myeloma

Phase NA Not yet recruiting

35 enrolled

Plasma cell

Multiple Myeloma

NCT06817759 2025-02-10

Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Hematological Cancer

Phase NA Not yet recruiting

60 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Anxiety Disorders, Lymphoma, Multiple Myeloma, Neoplasms, Pain, Hematologic Neoplasms

NCT06787807 2025-01-22

Proteomic Analysis of Patients Undergoing Bariatric Surgery

Phase NA Not yet recruiting

103 enrolled

BreastCNSGastrointestinalGenitourinaryGynecologicHead & NeckOtherPlasma cell

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Kidney Neoplasms, Liver Neoplasms, Meningioma, Multiple Myeloma, Neoplasms, Obesity, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms

NCT06769555 2025-01-10

BCMA/CD3 BiTE for RRAL or NDAL Amyloidosis With Insufficient Depth of Hematologic Response After Induction Therapy

Phase NA Not yet recruiting

20 enrolled

Plasma cell

Immunoglobulin Light-chain Amyloidosis

NCT06594211 2024-09-19

Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cells (ACT-001) in Patients With Relapsed or Refractorymultiple Myeloma

Phase NA Not yet recruiting

18 enrolled

Plasma cell

Multiple Myeloma

NCT06472479 2024-06-28

LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma

Phase NA Not yet recruiting

66 enrolled

Plasma cell

Multiple Myeloma

NCT06450821 2024-06-10

PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy Complications

Phase NA Not yet recruiting

60 enrolled

Classical hematologyPlasma cell

Neoplasms, Periodontitis, Stomatitis, Neoplasms, Plasma Cell, Febrile Neutropenia

NCT06262789 2024-02-16

RAT-HEMATO

Phase NA Not yet recruiting

264 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma

Clinical Trials

FAST-M

SAPPHIRE-MM

A Clinical Study Evaluating the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Three or More Lines of Treatment

Effects of Controlled Breathing on Cardiorespiratory Variables in Multiple Myeloma

KORMED-PA Stud

Effects of Controlled Breathing Added to Therapeutic Exercise in Multiple Myeloma

Application Study of 68Ga-NOTA-BCMA Nanoantibody Imaging in Multiple Myeloma

MFM

FOCUS

Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers

Effects of a Resistance Physical Exercise Program in Multiple Myeloma Patients

HiFi-MM

CAR-T

ETCABIO

Phase II Clinical Study on the Safety and Efficacy of Combined CAR-T Therapy Following Autologous Stem Cell Transplantation in Multiple Myeloma

GustaborPilot

A Study on the Use of Sulpegfilgrastim to Prevent the Incidence of Neutropenia With Infection in Newly Diagnosed Non-transplant Multiple Myeloma Patients

DKPD

MM-ZTE-II

LCAR-M61SQ in Treatment of Relapsed/Refractory Multiple Myeloma

Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Hematological Cancer

Proteomic Analysis of Patients Undergoing Bariatric Surgery

BCMA/CD3 BiTE for RRAL or NDAL Amyloidosis With Insufficient Depth of Hematologic Response After Induction Therapy

Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cells (ACT-001) in Patients With Relapsed or Refractorymultiple Myeloma

LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma

PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy Complications

RAT-HEMATO